thymidine has been researched along with metribolone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bevilacqua, MG; Calderaro, C; Caronti, B; Esposito, V; Gulino, A; Jaffrain-Rea, ML; Palladini, G; Petrangeli, E; Tamburrano, G | 1 |
Esquenet, M; Heyns, W; Swinnen, JV; Verhoeven, G | 1 |
Agoulnik, IU; Alvarado, M; Ayala, GE; Bingman, WE; Erdem, H; Frolov, A; Ittmann, MM; Nakka, M; Smith, CL; Vaid, A; Weigel, NL | 1 |
3 other study(ies) available for thymidine and metribolone
Article | Year |
---|---|
Effects of gonadal steroids on the growth of human pituitary adenomas in vitro.
Topics: Adenoma; Adult; Androgens; Bromocriptine; Cell Division; Dihydrotestosterone; Estradiol; Female; Follicle Stimulating Hormone; Growth Hormone; Hormone Antagonists; Humans; Lisuride; Male; Metribolone; Middle Aged; Pituitary Neoplasms; Progesterone; Prolactin; Receptors, Estrogen; Receptors, Progesterone; Testosterone; Thymidine; Tritium; Tumor Cells, Cultured | 1995 |
LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids.
Topics: Acid Phosphatase; Calcitriol; Carrier Proteins; Cell Division; Diazepam Binding Inhibitor; ErbB Receptors; Humans; Male; Metribolone; Neoplasms, Hormone-Dependent; Prostate-Specific Antigen; Prostatic Neoplasms; RNA, Messenger; RNA, Neoplasm; Testosterone Congeners; Thymidine; Tretinoin; Tumor Cells, Cultured | 1997 |
Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.
Topics: Androgens; Cell Line, Tumor; Cell Proliferation; Exons; Humans; Immunohistochemistry; Introns; Male; Metribolone; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Nuclear Receptor Coactivator 2; Prostatic Neoplasms; Receptors, Androgen; Thymidine | 2006 |